Time of Day Matters for Immunochemotherapy in Lung Cancer

(MedPage Today) -- Patients with advanced non-small cell lung cancer who received immunochemotherapy in the morning or early afternoon had better survival outcomes compared with patients who received treatment later in the day, a phase III randomized...